NUE

Nucor
D

NUE

Arincen63/100B

Nucor return on equity (ROE)

Nucor's return on equity is 16.52%: net income of 3.77B USD over the last twelve months on shareholders' equity of 22.81B USD.

Today
16.52%
Average, 5 years
25.92%
Low, 5 years
7.75%
High, 5 years
56.62%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 3.77B ÷ 22.81B = 16.52%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

What drives Nucor's return on equity?

Net margin
5.4%
profit on each dollar of sales
Asset turnover
0.93×
sales on each dollar of assets
Equity multiplier
1.68×
assets on each dollar of equity
Return on equity
8.3%
FY2025
  • FY20255.4% × 0.93 × 1.68 = 8.3%
  • FY20246.6% × 0.91 × 1.67 = 10.0%
  • FY202313.0% × 0.98 × 1.69 = 21.6%
  • FY202218.3% × 1.28 × 1.76 = 41.3%
  • FY202118.7% × 1.41 × 1.84 = 48.7%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today16.52%3.77B22.81B
FY202531 Dec 20259.73%2.04B20.94B
FY202431 Dec 202411.43%2.32B20.29B
FY202331 Dec 202323.46%4.91B20.94B
FY202230 Dec 202243.87%8.08B18.41B
FY202131 Dec 202150.81%7.12B14.02B
FY202031 Dec 20207.75%836.03M10.79B
FY201931 Dec 201913.24%1.37B10.36B
FY201831 Dec 201825.34%2.48B9.79B
FY201731 Dec 201715.80%1.38B8.74B
FY201631 Dec 201611.43%900.42M7.88B
FY201531 Dec 20152.60%193.03M7.42B
FY201431 Dec 201410.02%778.56M7.77B
FY201331 Dec 20137.66%585.53M7.65B
FY201231 Dec 20127.76%593.13M7.64B
FY201131 Dec 201111.52%860.98M7.47B
FY201031 Dec 20102.90%206.32M7.12B
FY200931 Dec 2009-3.21%-237.18M7.39B
FY200831 Dec 200827.05%2.14B7.93B
FY200731 Dec 200728.79%1.47B5.11B
FY200631 Dec 200636.42%1.76B4.83B
FY200531 Dec 200530.62%1.31B4.28B
FY200431 Dec 200432.45%1.12B3.46B
FY200331 Dec 20032.68%62.78M2.34B
FY200231 Dec 20026.98%162.08M2.32B
FY200131 Dec 20015.13%112.96M2.20B
FY200031 Dec 200014.59%310.91M2.13B
FY199931 Dec 199910.81%244.60M2.26B
FY199831 Dec 199812.72%263.70M2.07B
FY199731 Dec 199715.69%294.50M1.88B
FY199631 Dec 199615.42%248.20M1.61B
FY199531 Dec 199519.86%274.50M1.38B
FY199431 Dec 199420.19%226.60M1.12B
FY199331 Dec 199313.69%123.50M902.20M
FY199231 Dec 199210.10%79.20M784.20M
FY199131 Dec 19919.09%64.70M711.60M
FY199031 Dec 199011.50%75.10M652.80M
FY198931 Dec 19899.89%57.80M584.40M
FY198831 Dec 198813.32%70.90M532.30M
FY198731 Dec 198711.80%50.50M428.00M
FY198631 Dec 198612.09%46.40M383.70M
FY198531 Dec 198516.36%58.50M357.50M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about Nucor's ROE

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.